Sotera Health Co.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US83601L1026
USD
18.51
-0.39 (-2.06%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
311.31
294.34
254.52
290.20
285.47
276.59
248.18
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
311.31
294.34
254.52
290.20
285.47
276.59
248.18
Raw Material Cost
136.84
137.02
134.42
141.22
142.95
139.22
136.79
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
39.94
40.74
40.28
66.15
36.91
31.84
43.04
Selling and Distribution Expenses
49.04
52.43
48.69
47.03
51.42
52.16
51.82
Other Expenses
-3.99
-4.07
-4.03
-6.62
-3.69
-3.18
-4.30
Total Expenditure (Excl Depreciation)
185.88
189.45
183.10
188.25
194.37
191.38
188.61
Operating Profit (PBDIT) excl Other Income
125.39999999999999
104.9
71.39999999999999
102
91.1
85.19999999999999
59.6
Other Income
4.86
0.54
-1.80
26.07
1.27
-5.68
2.71
Operating Profit (PBDIT)
159.17
141.01
110.99
167.73
135.56
120.00
103.35
Interest
39.94
40.74
40.28
66.15
36.91
31.84
43.04
Exceptional Items
-17.41
-45.80
-44.15
-16.91
-12.71
-32.55
-8.23
Gross Profit (PBDT)
174.47
157.32
120.11
148.98
142.52
137.37
111.38
Depreciation
28.89
35.58
41.38
39.71
43.19
40.47
41.07
Profit Before Tax
72.94
18.90
-14.82
44.96
42.75
15.14
11.01
Tax
24.54
10.94
-1.56
32.64
25.76
6.39
4.69
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
48.40
7.96
-13.26
12.32
16.99
8.75
6.30
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
48.40
7.96
-13.26
12.32
16.99
8.75
6.30
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
48.40
7.96
-13.26
12.32
16.99
8.75
6.30
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
550.47
511.28
414.09
404.91
470.16
422.76
429.39
Earnings per share (EPS)
0.17
0.03
-0.05
0.04
0.06
0.03
0.02
Diluted Earnings per share
0.17
0.03
-0.05
0.04
0.06
0.03
0.02
Operating Profit Margin (Excl OI)
40.29%
35.64%
28.06%
35.13%
31.91%
30.81%
24.0%
Gross Profit Margin
32.71%
18.51%
10.43%
29.18%
30.11%
20.1%
20.99%
PAT Margin
15.55%
2.7%
-5.21%
4.24%
5.95%
3.16%
2.54%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2025 is 5.78% vs 15.64% in Jun 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2025 is 505.00% vs 160.15% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2025 is 9.82% vs 24.56% in Jun 2025

stock-summary

Interest

QoQ Growth in quarter ended Sep 2025 is -1.97% vs 0.99% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

Compare Quarterly Results Of Sotera Health Co. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
311.31
321.39
-10.08
-3.14%
Other Operating Income
0.00
0.00
0.00
Total Operating income
311.31
321.39
-10.08
-3.14%
Raw Material Cost
136.84
140.93
-4.09
-2.90%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
39.94
4.07
35.87
881.33%
Selling and Distribution Expenses
49.04
109.75
-60.71
-55.32%
Other Expenses
-3.99
1.15
-5.14
-446.96%
Total Expenditure (Excl Depreciation)
185.88
266.26
-80.38
-30.19%
Operating Profit (PBDIT) excl Other Income
125.43
55.14
70.29
127.48%
Other Income
4.86
0.00
4.86
Operating Profit (PBDIT)
159.17
83.90
75.27
89.71%
Interest
39.94
4.07
35.87
881.33%
Exceptional Items
-17.41
-5.90
-11.51
-195.08%
Gross Profit (PBDT)
174.47
180.47
-6.00
-3.32%
Depreciation
28.89
28.76
0.13
0.45%
Profit Before Tax
72.94
45.17
27.77
61.48%
Tax
24.54
11.14
13.40
120.29%
Provisions and contingencies
0
0
0.00
Profit After Tax
48.40
34.03
14.37
42.23%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
48.40
34.03
14.37
42.23%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
48.40
34.03
14.37
42.23%
Equity Capital
0
0
0.00
Face Value
0.01
0.01
0.00
Reserves
550.47
882.30
-331.83
-37.61%
Earnings per share (EPS)
0.17
0.70
-0.53
-75.71%
Diluted Earnings per share
0.17
0.70
-0.53
-75.71%
Operating Profit Margin (Excl OI)
40.29%
17.16%
0.00
23.13%
Gross Profit Margin
32.71%
23.00%
0.00
9.71%
PAT Margin
15.55%
10.59%
0.00
4.96%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 31.13 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 5.78% vs 15.64% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 9.04% vs 8.47% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 4.84 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 505.00% vs 160.15% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 184.71% vs 224.09% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 15.43 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 9.82% vs 24.56% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 14.89% vs -0.37% in Sep 2024

Quarterly - Interest
Interest 3.99 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -1.97% vs 0.99% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 8.13% vs -22.96% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 40.29%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024